Novo for sure knows who we are because we are using their Wegovy weight loss drug in a combo trial along with our monotrial. I am sure they will be watching closely for the outcome of SKYE's data. Also, SKYE's collaboration with Arecor is interesting because Eli Lilly and Sanofi are also in collaboration with Arecor for other meds, well Eli and Sanofi are both VERY interested in weight loss meds. So, let's see how this plays out. If SKYE can have a drug that supports weight loss without the psychiatric effects, I think we will be golden. These 2A results are going to be HUGE. I think there are a lot of big companies watching. And I think one will pull the trigger on SKYE a lot sooner than later. Probably before the 2A results come out. We will see. $NVO $SKYE

Absolutely right.,

What recession? Dow 50,000. Bullish

Solid insight! Bullish on $AMD.

I agree with your analysis.  $F is a great stock for the savvy dividend investor.

Rumor has it, they are willing to work for less pay and less benefits.

Financial metrics are a nightmare….

I didn't have a chance to watch yet either, but I read that Vivek Ramaswamy was the defacto winner, but that he served as a proxy for Trump.  I heard DeSantis came out the loser, or at least did nothing to help himself.

Did you watch the first GOP debate? What did you think?

$DUST. SUBSTANTIALLY OVERSOLD. Headed back above $25. Check its chart. Interest rates are headed higher which will strengthen the dollar. Gold is headed to $1,650. It has to compete with crypto currencies especially Bitcoin that is headed to $100,000. Buy a few shares today for the move higher.